Several genetic mutations have been implicated in familial (primarily early-onset) AD; however, for the more common late onset AD, while genome wide association studies have detected a number of single nucleotide polymorphisms [6–9], most of these polymorphisms, apart from the apolipoprotein E (APOE) gene, have a small effect on AD risk [10]. This evidence concerns the gene APOE and Alzheimer disease.